53 results
PRE 14A
EQ
Equillium Inc
31 Mar 23
Preliminary proxy
4:02pm
and Mr. Steel are not considered independent because of their current employment with us.
BOARD LEADERSHIP STRUCTURE
Our Board is currently chaired … Lilly and as Executive Director of Investor Relations. Before joining Amylin, Ms. Zedelmayer held various leadership positions within project
8-K
EX-99.1
qt31taps usbz
23 Dec 22
Equillium and Metacrine Mutually Agree to Terminate Definitive Merger Agreement
4:11pm
425
myab8cpomezqara36m7l
6 Dec 22
Business combination disclosure
7:02am
8-K
jwlyija6vjhwva
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
8-K
EX-99.1
e5bctk
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
8-K
EX-99.2
n796zezb z3jle
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
425
f3h1urh
14 Nov 22
Business combination disclosure
4:20pm
8-K
EX-99.1
6xwgprg
14 Nov 22
Equillium Reports Third Quarter 2022 Financial Results and Provides Corporate and Clinical Updates
4:10pm
424B3
kz6yoo1vg7n
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
0wdg7k
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
kf29k9
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
gr027ptuu7ms kld3sit
27 Sep 22
Business combination disclosure
9:30am
8-K
bhmlwkwa
27 Sep 22
Other Events
9:28am
8-K
EX-99.1
k6p2m pbh1m6x360
27 Sep 22
Other Events
9:28am
425
uap zzshbk9
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-99.2
tu4bpru
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm